fda glp-1 warning october 2025 issued 25 letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA Says to Drop Suicide

Others, however, dont respond or develop problematic side effects that interfere with eating patterns in different ways, she says

The company has already filed regulatory applications in the United States, Europe and other markets seeking approval for its oral GLP-1 candidate, orforglipron, for obesity

Low incidence of hypoglycemia - when used as monotherapy or with metformin Decrease in blood pressure by 2-7 mm Hg (in patients with hypertension)

"Fortunately, these medications, to date, have proven to be comparatively low risk," said Dr

Customer reviews are not provided for consumer reference

Some people taking both medications report virtually no appetite at all, which can make eating feel like a chore rather than an enjoyable part of life